→Appendix 1: NSAIDs
PDF page 1232
▶Common or very common Constipation. diarrhoea. ear
disorder. gastrointestinal discomfort. gastrointestinal
disorders. nausea. oedema. skin reactions. tinnitus
▶Uncommon Anxiety. asthenia. confusion. dizziness.
drowsiness. dry mouth. dyspnoea. eye disorder.
haemorrhage. headache. hyperhidrosis. insomnia.
myopathy. oral disorders. paraesthesia. photosensitivity
reaction. respiratory disorders. urinary tract disorder.
visual impairment. vomiting
▶Rare or very rare Alopecia. angioedema. hepatic disorders
. hypersensitivity. menorrhagia. nephrotic syndrome.
pancreatitis. renal failure (more common in patients with
pre-existing renal impairment). severe cutaneous adverse
reactions (SCARs). thrombocytopenia
▶Frequency not known Agranulocytosis. aplastic anaemia.
asthma. Crohn’s disease aggravated. depression. fertility
decreased female. haemolytic anaemia. hallucination.
heart failure. hypertension. increased risk of arterial
thromboembolism. leucopenia. malaise. meningitis
aseptic (patients with connective-tissue disorders such as
systemic lupus erythematosus may be especially
susceptible). nephritis tubulointerstitial. neutropenia.
optic neuritis. vertigo
SIDE-EFFECTS, FURTHER INFORMATION For information
about cardiovascular and gastrointestinal side-effects, and
a possible exacerbation of symptoms in asthma, see Non-
steroidal anti-inflammatory drugs p. 1193
PDF page 1232
Caution—long-term
use of some NSAIDs is associated with reduced female
fertility, which is reversible on stopping treatment.
PDF page 1233
Avoid unless the potential benefit outweighs
the risk. Avoid during the third trimester (risk of closure of
fetal ductus arteriosus in utero and possibly persistent
pulmonary hypertension of the newborn); onset of labour
may be delayed and duration may be increased.
PDF page 1233
Use with caution during breast-feeding.
Manufacturer advises avoid.
PDF page 1233
Manufacturer advises caution in
mild to moderate impairment; avoid in severe impairment.
PDF page 1233
Avoided if possible or use with
caution. Avoid in severe impairment.
Dose adjustments The lowest effective dose should be used
for the shortest possible duration.
Monitoring In renal impairment monitor renal function;
sodium and water retention may occur and renal function
may deteriorate, possibly leading to renal failure.
PDF page 1233